Abstract
Objective
The objective was to examine the effect of antenatal corticosteroid treatment on premature infants, with special attention to any possible adverse effects on neonatal outcome.
Methods
A retrospective chart review of all singleton and multiple pregnancies delivered in our perinatal center between 1991 and 1999, who had a birth weight of ≤1,500 g and who were subsequently admitted to our neonatal intensive care unit. Three hundred and sixty-five infants were included in the study and divided into two groups. One group had a gestational age below 28 weeks (≤196 days) and one group was 28 weeks (>196 days) onward.
Results
Antenatal corticosteroid therapy reduced the duration of mechanical ventilation, the need for supplementary oxygen, and the need for exogenous surfactant in neonates born at >196 days’s gestation (p<0.05). Corticosteroid treatment seemed to benefit the respiratory distress syndrome (RDS; p=0.051) in this group. There were less cases of necrotizing enterocolitis and neonatal death in the group with corticosteroid treatment (p<0.05). Before 28 weeks’ gestation, all parameters that were examined (e.g., duration of mechanical ventilation, need for supplemental oxygen, need for exogenous surfactant, RDS) showed no significant differences between those pregnancies pre-treated with corticosteroids or those not treated with corticosteroids. There was no adverse effect of corticosteroids on chorioamnionitis and early onset sepsis in pregnancies with a premature rupture of the membranes. Repeated corticosteroid treatment had no effect on birth weight, but did not improve neonatal outcome either. The interval between last corticosteroid treatment and delivery had no influence on RDS. There was no effect of corticosteroids on periventricular leukomalacia and intraventricular hemorrhage. Regression analysis showed a higher risk of severe RDS in multiple gestations.
Conclusion
Antenatal betamethasone treatment reduces perinatal morbidity and mortality after 28 weeks’ gestation. We found no adverse effects and also no benefit of repetitive corticosteroid treatment. The interval between last corticosteroid treatment and delivery did not influence the incidence of RDS. Dose, timing, and rate of antenatal corticosteroids should be reconsidered in multiple gestations.
Similar content being viewed by others
References
Liggins G (1969) Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 45:515
Crowley P (2000) Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2:CD0000665
National Institutes of Health (NIH) Consensus Development Panel (1995) Effect of corticosteroids for fetal maturation on perinatal outcomes. Am J Obstet Gynecol 173:246–252
Liggins G, Howie R (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515–525
Banks B, Cnaan A, Morgan A, Parer J, Merrill J, Ballard P, Ballard R, North American Thyrotropin-Releasing Hormone Study Group (1999) Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol 181:709–717
Jobe A, Wada N, Berry L, Ikegami M, Ervin M (1998) Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 178:880–885
Stewart J, Gonzales C, Christensen H, Rayburn W (1997) Impact of multiple antenatal doses of betamethasone on growth and development of mice offspring. Am J Obstet Gynecol 177:1138–1144
Ikegami M, Jobe A, Newnham J, Polk D, Willet K, Sly P (1997) Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 156:178–184
McEvoy C, Bowling S, Williamson K, Collins J, Tolaymat L, Maher J (2000) Timing of antenatal corticosteroids and neonatal pulmonary mechanics. Am J Obstet Gynecol 183:895–899
Matthews S (2000) Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 47:291–300
Smith G, Kingdom J, Penning D, Matthews S (2000) Antenatal corticosteroids: is more better? Lancet 355:251–252
McKenna D, Wittbert G, Samuels P (1999) The effects of repeated doses of antenatal corticosteroids on maternal adrenal function. Am J Obstet Gynecol 180:15
Jazayeri A, Gavrila D, Sincich T (2001) Repeated antenatal corticosteroid treatments. Do they reduce neonatal morbidity? J Reprod Med 46:788–790
Walfisch A, Hallak M, Mazor M (2001) Multiple courses of antenatal steroids: risks and benefits. Obstet Gynecol 98:491–497
Kay HH, Bird IM, Coe CL, Dudley DJ (2000) Antenatal steroid treatment and adverse fetal effects: what is the evidence? J Soc Gynecol Investig 7:269–278
Thorp J, Jones A, Hunt C, Clark R (2001) The effect of multidose antenatal betamethasone on maternal and infant outcomes. Am J Obstet Gynecol 184:196–202
Vermillion ST, Soper DE, Newmann RB (2001) Is betamethasone effective longer than 7 days after treatment? Obstet Gynecol 97:491–493
Vermillion ST, Soper DE, Chasedunn-Roark J (1999) Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. Am J Obstet Gynecol 181:320–327
Baud O, Foix-L’Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, Huon C, Lepercq J, Dehan M, Lacaze-Masmonteil T (1999) Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 341:1190–1196
Salokorpi T, Sjaniemi N, Hällbäck H, Kari A, Rita H, von Wendt L (1997) Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatr 86:294–298
Garland JS, Buck R, Leviton A (1995) Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr 126:272–279
Ardila J, Le Guennec J, Papageorgiou A (1994) Influence of antenatal betamethasone and gender cohabitation on outcome of twin pregnancies 24 to 34 weeks of gestation. Semin Perinatol 18:15–18
Spinillo A, Capuzzo E, Ometto A (1995) Value of antenatal corticosteroid therapy in preterm birth. Early Human Dev 42:37–47
Crowley P (1995) Antenatal corticoid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 173:322–335
Burkett G, Bauer C, Morrison J, Curet L (1986) Effect of prenatal dexamethasone administration on prevention of respiratory distress syndrome in twin pregnancies. J Perinatol 6:304–308
Turrentine M, Wilson P, Wilkins I (1996) A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies. Am J Perinatol 13:351–354
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smrcek, J.M., Schwartau, N., Kohl, M. et al. Antenatal corticosteroid therapy in premature infants. Arch Gynecol Obstet 271, 26–32 (2005). https://doi.org/10.1007/s00404-004-0664-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-004-0664-4